| Peter John White, MD | |
|
400 N Pepper Ave, Colton, CA 92324-1801 | |
| (310) 227-1619 | |
| Not Available |
| Full Name | Peter John White |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 54 Years |
| Location | 400 N Pepper Ave, Colton, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326011461 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0000X | Pain Medicine - Pain Medicine | A50653 (California) | Primary |
| 207L00000X | Anesthesiology | A50653 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Arrowhead Regional Medical Center | Colton, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Inland Empire Anesthesia Medical Group, Inc | 1052310331 | 26 |
News Archive
Technology advances are making life better for the elderly and those with Alzheimer's disease by allowing the older to stay in their homes and giving the ill a way to interact with society again.
Brain imaging and cognitive tests may be the gold standards for tracking Alzheimer disease progression, but clinical trials using these procedures are expensive, risky, and time-consuming, making the development of reliable go-betweens a pressing goal for AD researchers.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Gabapentin Capsules USP, 100 mg, 300 mg and 400 mg, the generic version of Pfizer's Neurontin® Capsules used to treat a painful complication of shingles.
A preliminary study by New Zealand company Plant & Food Research shows that natural chemicals from blackcurrants may help breathing in some types of asthma.
Pharmacyclics, Inc. today announced that longer-term toxicology studies for its newly developed Bruton's tyrosine kinase (BTK) inhibitor for rheumatoid arthritis, or RA, have been completed.
› Verified 4 days ago
| Entity Name | Inland Empire Anesthesia Medical Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861502841 PECOS PAC ID: 1052310331 Enrollment ID: O20061214000268 |
News Archive
Technology advances are making life better for the elderly and those with Alzheimer's disease by allowing the older to stay in their homes and giving the ill a way to interact with society again.
Brain imaging and cognitive tests may be the gold standards for tracking Alzheimer disease progression, but clinical trials using these procedures are expensive, risky, and time-consuming, making the development of reliable go-betweens a pressing goal for AD researchers.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Gabapentin Capsules USP, 100 mg, 300 mg and 400 mg, the generic version of Pfizer's Neurontin® Capsules used to treat a painful complication of shingles.
A preliminary study by New Zealand company Plant & Food Research shows that natural chemicals from blackcurrants may help breathing in some types of asthma.
Pharmacyclics, Inc. today announced that longer-term toxicology studies for its newly developed Bruton's tyrosine kinase (BTK) inhibitor for rheumatoid arthritis, or RA, have been completed.
› Verified 4 days ago
| Entity Name | Pain Rehabilitation & Critical Care Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659569226 PECOS PAC ID: 7911067582 Enrollment ID: O20081201000149 |
News Archive
Technology advances are making life better for the elderly and those with Alzheimer's disease by allowing the older to stay in their homes and giving the ill a way to interact with society again.
Brain imaging and cognitive tests may be the gold standards for tracking Alzheimer disease progression, but clinical trials using these procedures are expensive, risky, and time-consuming, making the development of reliable go-betweens a pressing goal for AD researchers.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Gabapentin Capsules USP, 100 mg, 300 mg and 400 mg, the generic version of Pfizer's Neurontin® Capsules used to treat a painful complication of shingles.
A preliminary study by New Zealand company Plant & Food Research shows that natural chemicals from blackcurrants may help breathing in some types of asthma.
Pharmacyclics, Inc. today announced that longer-term toxicology studies for its newly developed Bruton's tyrosine kinase (BTK) inhibitor for rheumatoid arthritis, or RA, have been completed.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Peter John White, MD 210 N Tustin Ave, Santa Ana, CA 92705-3807 Ph: (714) 347-1010 | Peter John White, MD 400 N Pepper Ave, Colton, CA 92324-1801 Ph: (310) 227-1619 |
News Archive
Technology advances are making life better for the elderly and those with Alzheimer's disease by allowing the older to stay in their homes and giving the ill a way to interact with society again.
Brain imaging and cognitive tests may be the gold standards for tracking Alzheimer disease progression, but clinical trials using these procedures are expensive, risky, and time-consuming, making the development of reliable go-betweens a pressing goal for AD researchers.
Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Gabapentin Capsules USP, 100 mg, 300 mg and 400 mg, the generic version of Pfizer's Neurontin® Capsules used to treat a painful complication of shingles.
A preliminary study by New Zealand company Plant & Food Research shows that natural chemicals from blackcurrants may help breathing in some types of asthma.
Pharmacyclics, Inc. today announced that longer-term toxicology studies for its newly developed Bruton's tyrosine kinase (BTK) inhibitor for rheumatoid arthritis, or RA, have been completed.
› Verified 4 days ago